v
Search
Advanced

Publications > Journals > Journal of Exploratory Research in Pharmacology > Article Full Text

  • Original Article
  • OPEN ACCESS

Plantaricin LD1 Inhibits the Growth and Biofilm Formation of Staphylococcus aureus in Milk

  • Manoj Kumar Yadav ,
  • Anshu Baldia  and
  • Santosh Kumar Tiwari* 
 Author information  Cite
Journal of Exploratory Research in Pharmacology   2024;9(1):1-7

doi: 10.14218/JERP.2023.00011

Abstract

Background and objectives

Bacteriocins of probiotic lactic acid bacteria have been used as bio-preservatives to improve food safety and extend the storage period of some food types. This study explored the impact of plantaricin LDL, a bacteriocins purified from the potential probiotic strain, Lactobacillus plantarum LD1, on inhibiting the growth and biofilm formation of food spoilage bacteria in milk.

Methods

The antimicrobial and anti-biofilm activity of Plantaricin LD1 was determined against a food-borne pathogen, Staphylococcus aureus subsp. aureus ATCC 25923. The efficacy of plantaricin LD1 against S. aureus subsp. aureus ATCC 25923 was also tested in the milk.

Results

Plantaricin LD1 had a minimum inhibitory concentration of 79.16 µg/mL and minimum bactericidal concentration of 158.33 µg/mL against S. aureus subsp. aureus ATCC 25923. Biofilm formation of S. aureus subsp. aureus ATCC 25923 was completely inhibited in the presence of 79.16 µg/mL of plantaricin LD1. Complete loss of cell viability in milk was observed after treatment with double minimum inhibitory concentration (158.33 µg/mL) of plantaricin LD1 at 48 hrs.

Conclusions

Our findings illustrate the antimicrobial and anti-biofilm activity of plantaricin LD1 against S. aureus subsp. aureus ATCC 25923 in milk. These results suggest that plantaricin LD1 can be used as a natural preservative to expand the shelf-life of milk.

Keywords

Food preservatives, Lactobacillus plantarum LD1, Plantaricin LD1, Biofilm, Milk

Introduction

Food-borne diseases, caused by contamination of food products by spoilage bacteria, are a major concern for public health. Such contaminations not only alter the smell, taste and shelf-life of food products, but also cause significant threats to public health.1,2 Food contaminating pathogens such as Staphylococcus aureus, Escherichia coli, Listeria monocytogenes and Salmonella typhi are hard to eliminate altogether from food and the human environment.3S. aureus is a zoonotic pathogen that causes severe illnesses in humans and animals. It is also one of the major biofilm-forming pathogens responsible for mastitis in dairy animals around the world.4 It produces enterotoxins responsible for illnesses, such as bacteremia, toxic shock syndrome, staphylococcal food-borne poisoning (nausea, vomiting, abdominal cramps and diarrhea), abscess, infective endocarditis, sepsis and pneumonia.5S. aureus is common in the milk and other dairy products because milk-producing animals are the primary sources of S. aureus contamination. Other sources of contamination include human handling, milking equipment and the environment.4–6 The microbial niche generally constitutes biofilms composed of extracellular polymeric substances (EPS) like polysaccharides, proteins, lipids and extracellular DNA, which aid in microbial adhesion to various surfaces.7 An additional benefit is that bacteria living in biofilms are several times more resistant to antimicrobials than their planktonic counterparts.8 Inhibiting biofilm formation by pathogens is a major challenge during the treatment of various infectious diseases.9

Food industries have adopted several types of preservation strategies to prevent the growth of spoilage microorganisms in food products.10 Preservatives in foods primarily serve as flavor enhancers, nutritional quality boosters, spoilage delay agents, and inhibitors of microbial growth and biofilm formation.11 In recent years, chemical preservatives have become one of the most popular and cost-efficient methods for preserving several foods.10 Sodium benzoates, sodium nitrite, potassium sorbate, etc. are among the most widely used chemical food preservatives.12 These preservatives have been effective at inhibiting food-borne pathogens, but they also cause resistance development in pathogens as well as changes to the organoleptic property of the food.13 The increasing demand of consumers for ‘safe-to-eat’ food has ignited curiosity for the development of valuable natural biopreservatives.14 Natural antimicrobials, such as bacteriocins of lactic acid bacteria (LAB), are useful alternatives to chemical-based food preservatives.15 LAB bacteriocins in particular, are of interest because they are deemed safe for use in the food industry.

Bacteriocins of probiotic LAB are safe for human consumption, non-carcinogenic and non-allergic.16 These bacteriocins have low molecular weights (∼3 to 10 kDa), are hydrophobic and cationic peptides, and are stable in many organic solvents, polymers and detergents. They also exhibit stability at low pH and high temperature but are unstable in the presence of proteolytic enzymes.17 Due to their proteinaceous nature and being produced by food-grade LAB, bacteriocins do not induce toxicity. The biochemical and genetic properties of bacteriocins provide a valid reason for their consideration as food preservatives.18 Bacteriocins differ from antibiotics due to their proteinaceous nature and their ease of digestion by protease enzymes in the human digestive system.19,20 Bacteriocins such as nisin and pediocin PA-1 have been reported as having applications in food preservation.21 Nisin and pediocin PA-1/AcH are the only commercially available bacteriocins under the name Nisaplin™ and Alta 2341™ or Microgard™, respectively.22 Nisin, which has been approved by the United States Food and Drug Administration (USFDA), is used for the safety of processed cheese, dairy products and canned foods.17 Therefore, it is necessary to explore other bacteriocins which may have potential applications in food safety.

Previously, plantaricin LD1 was purified from the cell-free supernatant (CFS) of Lactobacillus plantarum LD1 isolated from batter of Dosa in our laboratory.23 The bacteriocin was cationic, with a molecular weight of 6.5 kDa, heat stable and showed antimicrobial activity against broad range of bacteria (Micrococcus luteus MTCC 106, L. delbrueckii NRRL B-4525, Lactococcus lactis NRRL B-1821, L. acidophilus NRRL B-4495, L. curvatus NRRL B-4562, E. faecium NRRL B-2354, L. lactis cremoris NRRL B-634, Pseudomonas fluorescens, E. coli (urogenic), P. aeruginosa, S. aureus, Vibrio sp., Shigella flexneri and S. typhi).23,24 In this study, the inhibitory effect of plantaricin LD1 was investigated against a food-borne pathogen; S. aureus subsp. aureus ATCC 25923 in milk.

Methods

Bacterial strains and growth conditions

L. plantarum LD1 was grown in MRS (de Man, Rogosa and Sharpe) medium (1% beef extract, 0.005% manganese sulphate, 2% glucose, 0.2% ammonium citrate, 0.5% yeast extract, 0.5% sodium acetate, 0.01% magnesium sulphate, 0.1% tween 80, 1% proteose peptone, 0.2% dipotassium hydrogen phosphate, pH 6.5) at 37°C for 18 hrs under the static condition in a BOD incubator (Laby Instrument, Haryana, India).23,25M. luteus MTCC 106 and S. aureus subsp. aureus ATCC 25923 were grown in Nutrient Broth (NB) medium (0.5% pepsin, 0.5% sodium chloride, 0.15% yeast extract, 0.15% beef extract, pH 7.4). E. coli ATCC 25922 was grown in Luria-Bertani (LB) broth medium (1.0% casein enzyme hydrolysate, 1.0% sodium chloride, 0.5% yeast extract, pH 7.5) at 37°C for 18 hrs with continuous shaking at 200 rpm in an incubator shaker (Scigenics, Tamil Nadu, India).26 The chemicals and media components were purchased from Sisco Research Laboratory (Mumbai, India) and HiMedia (Mumbai, India). Nisin was purchased from Sigma (St. Louis, USA). Milk (Vita, Haryana, India) was purchased from the local market of Rohtak, Haryana, India. The ingredients of milk are carbohydrates 5.10 g, fat 1.50 g, protein 3.30 g, calcium 150 mg, vitamin A (Retinol Palmitate) 36 µg and vitamin D (Ergocalciferol) 0.62 µg.

Preparation of purified plantaricin LD1

The cell-free supernatant (CFS) of L. plantarum LD1 was used to purify the plantaricin LD1 as described in our previous study.25 Briefly, sterilized CFS was passed successively through a 3 kDa nominal molecular weight cut-off (NMWCO) hollow fiber cartridge equipped with AKTA Flux-S (GE Healthcare, Uppsala, Sweden). The retentate was collected in a sterile container and loaded onto a cation-exchange HiPrep SP FF 16/10 (1.6 × 10 cm, 20 mL) column equipped with AKTAprime plus system (GE Healthcare, Uppsala, Sweden). Agar well diffusion assay (AWDA) was used to determine the antimicrobial activity after the fractions (1 mL) were collected. Gel-filtration chromatography (GFC) using a sephadex G-50 column (1.6 × 50 cm, 100 mL) equipped with AKTA prime plus system was used to desalt the pooled cation-eluted active fractions. The protein concentration of plantaricin LD1 was determined using the Bradford assay. The antimicrobial activity of plantaricin LD1 was determined against M. luteus MTCC 106, E. coli ATCC 25922 and S. aureus subsp. aureus ATCC 25923 using AWDA. Nisin was used as a positive control (Table 1).

Table 1

Antimicrobial activity of plantaricin LD1 and nisin against different bacteria

Target bacteriaZone of growth inhibition (mm)
Plantaricin LD1Nisin
Micrococcus luteus MTCC 1062025
Escherichia coli ATCC 259229Nil
Staphylococcus aureus subsp. aureus ATCC 259232016

Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)

The sodium acetate buffer (10 mM, pH 4.5) was used to prepare a two-fold serial dilution of plantaricin LD1 and 100 µL of each dilution was transferred to the wells of microtiter plates already containing 200 µL of S. aureus subsp. aureus ATCC 25923 with an initial OD600 of 0.02 in NB medium. The control set was supplemented with 100 µL of sodium acetate buffer in place of plantaricin LD1. The microtiter plate was incubated in a BOD incubator shaker for 18 hrs at 37°C with constant shaking at 200 rpm. Net growth was calculated by subtracting the final and initial OD600 using a microplate reader (Molecular Devices, San Jose, USA). The lowest concentration of plantaricin LD1 which showed no observable growth (OD600 < 0.1) of the target strains was considered the MIC and the MBC as the lowest concentration of plantaricin LD1 when complete loss of cell viability was recorded.26

Inhibition of biofilm formation

The crystal violet (CV) method was used to measure the inhibition of biofilm formation as described previously by Yadav et al.27 Briefly, a microtiter plate was filled with 200 µL of an overnight grown culture (∼106 CFU/mL) of S. aureus subsp. aureus ATCC 25923 and various concentrations of plantaricin LD1 (0–316.66 µg/mL) were added to each well and incubated at 37°C for 18 hrs with constant shaking at 200 rpm. For control samples, sodium acetate buffer (10 mM, pH 4.5) was added to the well instead of plantaricin LD1. After incubation, the liquid content was decanted and rinsed twice with filter-sterilized phosphate-buffered saline (PBS, pH 7.4) to remove the cells of the indicator strain and the growth medium. The biofilm was then fixed in the microtiter plate wells by adding absolute methanol (150 µL) and incubated at room temperature for 20 mins. The wells were then twice rinsed using filter sterilized double-distilled water (ddH2O) and air dried for 30 mins in the inverted position. The biofilm was stained with 200 µL crystal violet (CV) solution (0.1%), and incubated for 15 mins at room temperature before the unbounded dye was removed by washing with ddH2O. The bound dye was then released by adding an aliquot (150 µL) of acetic acid (33%) and incubating at room temperature for 30 mins. To determine the amount of biofilm formation, the optical density (OD) of the dye released was measured at 585 nm using a microplate reader.

Effect of plantaricin LD1 in milk

The efficacy of plantaricin LD1 against S. aureus subsp. aureus ATCC 25923 was evaluated in sterilized milk (Vita, Haryana, India). The overnight grown culture of S. aureus subsp. aureus ATCC 25923 (OD600 0.02) was added to 5 mL of sterilized milk and treated with MIC (79.16 µg/mL) and double MIC (158.33 µg/mL) of plantaricin LD1. A set without plantaricin LD1 was used as a control. The untreated and treated sets were incubated for 48 hrs at 37°C in an incubator with constant shaking at 200 rpm. The colony-forming units per milliliter (CFU/mL) were calculated to estimate the cell viability of the target strain.28

Statistical analysis

Experiments were carried out in triplicate and mean values and standard deviations (mean ± SD) were plotted using SigmaPlot 11.0. Statistically significant results (p < 0.05) were ascertained using the student t-test.

Results

Growth inhibition of S. aureus subsp. aureus ATCC 25923

The untreated set of S. aureus subsp. aureus ATCC 25923 showed growth up to OD600 1.37 ± 0.043. The plantaricin LD1-treated cells showed a reduction trend in the growth up to OD600 0.00 ± 0.04 at different concentrations (4.94–316.66 µg/mL). Therefore, 79.16 µg/mL was considered MIC of plantaricin LD1. Cell viability of S. aureus subsp. aureus ATCC 25923 decreased up to log10 nil CFU/mL in the presence of different concentrations (4.94–316.66 µg/mL). Therefore, 158.33 µg/mL was considered as MBC of plantaricin LD1 (Fig. 1). The percentage growth inhibition and percentage inhibition of cell viability were increased to 100 percent after treatment with different concentrations of plantaricin LD1 (4.94–316.66 µg/mL) (Table 2).

Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of plantaricin LD1 against <italic>Staphylococcus aureus</italic> subsp. <italic>aureus</italic> ATCC 25923.
Fig. 1  Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of plantaricin LD1 against Staphylococcus aureus subsp. aureus ATCC 25923.

The results are expressed a mean ±SD (n=3). CFU, colony forming units; MBC, minimum bactericidal concentration; MIC, minimum inhibitory concentration; OD, optical density.

Table 2

Percentage inhibition of growth, cell viability and biofilm formation of Staphylococcus aureus subsp. aureus ATCC 25923 after treatment with plantaricin LD1

S. No.Different concentrations of plantaricin LD1 (µg/mL)Percentage growth inhibitionPercentage inhibition of cell viabilityPercentage inhibition of biofilm formation
1.0000
2.4.9415.3312.7521.74
3.9.8920.4026.0843.48
4.19.7927.7440.0065.22
5.39.5861.3154.9078.26
6.79.1694.1685.3597.83
7.158.3399.27100.0098.26
8.316.66100.00100.00100.00

Inhibition of biofilm formation

Optical density (OD585) readings for the untreated set of S. aureus subsp. aureus ATCC 25923 was 0.23 ± 0.003, suggesting the formation of biofilm. Inhibition of biofilm formation by plantaricin LD1 was illustrated by a concentration dependent reduction in optical density absorbance at OD585 from 0.18 ± 0.008 to 0.00 ± 0.001 in the presence of different concentrations (4.94–316.66 µg/mL) (Fig. 2). At 79.16 µg/mL, plantaricin LD1 completely inhibited biofilm formation of S. aureus subsp. aureus ATCC 25923. The percentage of inhibition of biofilm formation was found 0.00 ± 0.002 to 100 ± 0.005 after treatment with various concentrations of plantaricin LD1 (4.94–316.66 µg/mL) as depicted in Table 2.

Inhibition of biofilm formation of <italic>Staphylococcus aureus</italic> subsp. <italic>aureus</italic> ATCC 25923 in the presence of different concentrations of plantaricin LD1.
Fig. 2  Inhibition of biofilm formation of Staphylococcus aureus subsp. aureus ATCC 25923 in the presence of different concentrations of plantaricin LD1.

Kill kinetics of S. aureus subsp. aureus ATCC 25923 in Milk

Milk without (control) plantaricin LD1 showed increased growth of S. aureus subsp. aureus ATCC 25923 with time, and recorded log10 9.5 ± 0.18 CFU/mL at 48 hrs. Milk treated with MIC (79.16 µg/mL) of plantaricin LD1 showed a decrease in cell viability to log10 1.12 ± 0.20 CFU/mL at 48 hrs. The complete loss of cell viability of S. aureus subsp. aureus ATCC 25923 was found after treatment with double MIC (158.33 µg/mL) of plantaricin LD1 at 48 hrs (Fig. 3). This suggested that plantaricin LD1 caused killing of S. aureus subsp. aureus ATCC 25923 cells in milk.

Kill kinetics of <italic>Staphylococcus aureus</italic> subsp. a<italic>ureus</italic> ATCC 25923 in the presence of MIC (79.16 µg/mL) and double MIC (158.33 µg/mL) of plantaricin LD1 as compared to untreated cells in the milk.
Fig. 3  Kill kinetics of Staphylococcus aureus subsp. aureus ATCC 25923 in the presence of MIC (79.16 µg/mL) and double MIC (158.33 µg/mL) of plantaricin LD1 as compared to untreated cells in the milk.

CFU, colony forming units; MIC, minimum inhibitory concentration.

Discussion

Food-borne pathogenic bacteria grow in a wide range of food materials such as dairy, meat and vegetable products.29 Preservation techniques such as canning, pasteurization and addition of preservatives are standard,30 and cause adverse effects such as allergic reactions, formation of carcinogenic products and alteration of the sensory properties of the foods.31 The presence of S. aureus biofilm on food comes with a severe risk of diseases associated with the consumption of contaminated fresh or processed foods. The use of probiotic bacteria and their metabolic products has promising applications in ensuring the safety and enhancement of the shelf-life of foods by inhibiting food-borne pathogens.32 Bacteriocins of probiotic LAB are broadly utilized in food safety because of their non-toxic nature, categorized as ‘Generally Regarded as Safe’ (GRAS) and inhibit the growth of food-borne pathogens.33,34 Different species of Staphylococcus are responsible for causing skin and soft tissue infections that can be life-threatening. Although many bacteriocins have been reported to be active against food-borne pathogens, few of them have been diligently characterized for their application in food safety.15

Our previous research demonstrated that crude plantaricin LD1 from L. plantarum LD1 is thermostable, pH-stable, sensitive to proteolytic enzymes, stable in the presence of various organic solvents and has antimicrobial activity against related bacteria and some food-borne pathogens.24 It also has bactericidal activity against S. aureus subsp. aureus ATCC 25923, as previously demonstrated by Gupta and Tiwari.24 In this study, we demonstrated inhibition of growth and biofilm formation by the food-borne pathogen, S. aureus subsp. aureus ATCC 25923 in milk using purified plantaricin LD1. The MIC of purified plantaricin LD1 was 76.16 µg/mL against S. aureus subsp. aureus ATCC 25923. Similarly, bacteriocin MN047A from L. crustorum MN047 showed MIC 165 µg/mL against S. aureus ATCC 29213 which is almost double.35 Plantaricin Pln1 required an even higher concentration (475 µg/mL) to inhibit the growth of S. aureus ATCC 29213.36 In another study, the bacteriocin XN2 from Lacticaseibacillus rhamnosus XN2 required a higher concentration (100 µg/mL) for growth inhibition of S. aureus CICC 10384 as compared to plantaricin LD1.37 Gong et al.38 also suggested that the plantaricin MG produced by L. plantarum KLDS1.0391 required higher concentration (1,000 µg/mL) for the inhibition of growth of S. aureus ATCC 25923. In addition, bacteriocin SLG10 from L. plantarum SLG10 and plantaricin 827 from L. plantarum 163 inhibited S. aureus CICC 10384 and S. aureus ATCC 25923, respectively.39,40 In contrast, Barbosa et al.41 suggested that the bacteriocin MBSa4 isolated from L. plantarum MBSa4 did not inhibit S. aureus ATCC 29213.

Microbial biofilms harbor complex microbial communities which allow microbes to adhere tightly to surfaces. This is an essential characteristic for the survival of various microorganisms.8,39 Antimicrobial peptides (AMPs) inhibit biofilm formation by interacting with extracellular DNA and facilitating surface detachment.42 Consequently, naturally produced AMPs have become a focus point for research aimed at mitigating the spread of pathogenic organisms.43 AMPs derived from natural sources, such as bacteriocins, also represent an attractive and interesting alternative for the treatment of bacterial infections resulting from multidrug-resistant microorganisms.44 Their potential as supplements or replacements for antibiotics could be an environmentally friendly approach to encouraging reduction in antibiotic overuse and resistance.45 In this study, plantaricin LD1 completely inhibited biofilm development by S. aureus subsp. aureus ATCC 25923. In another study, the biofilm of S. aureus ATCC 25923 was inhibited by plantaricin YKX from L. plantarum YKX, as suggested by Pei et al.46 Plantaricin GZ1-27 purified from L. plantarum GZ1-27 also inhibited biofilm formation of S. aureus ATCC 43300 by preventing the creation of surface matrix-associated proteins features.47 Plantaricin 827 from L. plantarum 163 and bacteriocin C4B from L. lactis F01 inhibited the biofilm formation of S. aureus ATCC 25923, ATCC 43300 and ATCC 35395, respectively.40,48 Milk is rich in macro and micronutrients and therefore it is a suitable medium for the growth of pathogenic bacteria.49S. aureus contamination in food has led to a significant need in the food industry for natural, secure and efficient antimicrobial agents that are capable of inactivating pathogenic bacteria from food.40 Plantaricin LD1 treatment of S. aureus subsp. aureus ATCC 25923 cells resulted in a time-bound bactericidal effect in milk. Similarly, Zhao et al.40 showed plantaricin 827 from L. plantarum 163 inactivating S. aureus ATCC 25923 in skim milk, and bacteriocin MN047A from L. crustorum MN047 showed loss in cell viability of S. aureus ATCC 29213 in a dose and time-dependent manner as suggested by Yi et al.35 Other bacteriocins, such as enterocin AS-48 and bacteriocin NX371 inhibited the growth of S. aureus CECT 976 and S. aureus (MRSA) ATCC 43300 in milk.2,50 This study is in alignment with the other studies suggesting the application of plantaricin LD1 for the safety of milk and related dairy products.

Future directions

Plantaricin LD1 is a non-toxic antimicrobial peptide purified from food-grade L. plantarum LD1, which is safe as a food preservative and medicine. The efficacy of plantaricin LD1 against the food-borne pathogen, S. aureus subsp. aureus ATCC 25923 in a milk model has highlighted its potential application in dairy industry food safety. The findings from this study have also emphasized the role of plantaricinLD1 as a potential antibiotic against clinical pathogens that cause infectious diseases.

Conclusions

Plantaricin LD1 purified from food isolate of L. plantarum LD1 has antimicrobial and anti-biofilm activity against the food-borne pathogen, S. aureus subsp. aureus ATCC 25923. Plantaricin LD1 treated milk remained fresh by inhibiting the cell viability of S. aureus subsp. aureus ATCC 25923. Therefore, plantaricin LD1 may be used as a natural food bio-preservative for the safety of milk.

Abbreviations

AWDA: 

agar well diffusion assay

BOD: 

biological oxygen demand

CEC: 

cation-exchange chromatography

CFS: 

cell-free supernatant

CV: 

crystal violet

EPS: 

extracellular polymeric substances

GFC: 

gel-filtration chromatography

LAB: 

lactic acid bacteria

MBC: 

minimum bactericidal concentration

MIC: 

minimum inhibitory concentration

MRS: 

de Man, Rogosa and Sharpe medium

NMWCO: 

nominal molecular weight cut-off

OD: 

optical density

PBS: 

phosphate-buffered saline

Declarations

Acknowledgement

The authors acknowledge fellowships by the Department of Biotechnology, New Delhi and Indian Council of Medical Research, New Delhi, India. MKY received the University Research Scholarship of the Department of Genetics, Maharshi Dayanand University, Rohtak, Haryana, India.

Data sharing statement

No additional data are available.

Funding

This work was financially supported by the Department of Biotechnology (BT/PR8911/NDB/39/423/2013), Indian Council of Medical Research (5/9/1117/2013-NUT), New Delhi, India. The University Grants Commission-Scheme for Trans-disciplinary Research for India’s Developing Economy Component-1 (UGC-STRIDE-1), New Delhi, India [F.2-16/2019 (STRIDE 1)] is acknowledged.

Conflict of interest

The authors have no conflict of interests related to this publication.

Authors’ contributions

MKY and AB performed the experiments, analyzed the data and designed the manuscript. SKT, as corresponding authors, provided all laboratory facilities, chemicals and reviewed the manuscript. All authors read and approved the final version of the manuscript.

References

  1. Todd E. Food-borne disease prevention and risk assessment. Int J Environ Res Public Health 2020;17(14):5129 View Article PubMed/NCBI
  2. Meng F, Zhu X, Zhao H, Nie T, Lu F, Lu Z, et al. A class III bacteriocin with broad-spectrum antibacterial activity from Lactobacillus acidophilus NX2-6 and its preservation in milk and cheese. Food Control 2021;121:107597 View Article
  3. Law JW, Ab Mutalib NS, Chan KG, Lee LH. Rapid methods for the detection of foodborne bacterial pathogens: Principles, applications, advantages and limitations. Front Microbiol 2014;5:770 View Article PubMed/NCBI
  4. Kou X, Cai H, Huang S, Ni Y, Luo B, Qian H, et al. Prevalence and characteristics of Staphylococcus aureus isolated from retail raw milk in Northern Xinjiang, China. Front Microbiol 2021;12:705947 View Article PubMed/NCBI
  5. Taban BM, Numanoglu Cevik Y. The efficiency of MALDI-TOF MS method in detecting Staphylococcus aureus isolated from raw milk and artisanal dairy foods. CyTA J Food 2021;19:739-750 View Article
  6. Avila-Novoa MG, Iñíguez-Moreno M, Solís-Velázquez OA, González-Gomez JP, Guerrero-Medina PJ, Gutiérrez-Lomelí M. Biofilm formation by Staphylococcus aureus isolated from food contact surfaces in the dairy industry of Jalisco, Mexico. J Food Qual 2018;2018:1-8 View Article
  7. Danilova ND, Solovyeva TV, Mart’Yanov SV, Zhurina MV, Gannesen AV. Stimulatory effect of epinephrine on biofilms of Micrococcus luteus C01. Microbiol 2020;89:493-497 View Article
  8. Talapko J, Škrlec I. The principles, mechanisms, and benefits of unconventional agents in the treatment of biofilm infection. Pharmaceuticals (Basel) 2020;13(10):299 View Article PubMed/NCBI
  9. Benmouna Z, Dalache F, Zadi-Karam H, Karam NE, Vuotto C. Ability of three lactic acid bacteria to grow in sessile mode and to inhibit biofilm formation of pathogenic bacteria. Adv Exp Med Biol 2020;1282:105-114 View Article PubMed/NCBI
  10. Zhang F, Zhang M, Chen Y, Ouyang J, Wang Y, Yang H, et al. Antimicrobial, anti-biofilm properties of three naturally occurring antimicrobial peptides against spoilage bacteria, and their synergistic effect with chemical preservatives in food storage. Food Control 2021;12:107729 View Article
  11. Gadea R, Glibota N, Pulido RP, Gálvez A, Ortega E. Effects of exposure to biocides on susceptibility to essential oils and chemical preservatives in bacteria from organic foods. Food Control 2017;80:176-182 View Article
  12. Silva MM, Lidon F. Food preservatives-An overview on applications and side effects. Emir J Food Agric 2016;28:366-373 View Article
  13. Leon Madrazo A, Segura Campos MR. Review of antimicrobial peptides as promoters of food safety: Limitations and possibilities within the food industry. J Food Saf 2020;40:e12854 View Article
  14. Udayakumar S, Rasika DM, Priyashantha H, Vidanarachchi JK, Ranadheera CS. Probiotics and beneficial microorganisms in biopreservation of plant-based foods and beverages. Appl Sci 2022;12:11737 View Article
  15. Silva CCG, Silva SPM, Ribeiro SC. Application of bacteriocins and protective cultures in dairy food preservation. Front Microbiol 2018;9:594 View Article PubMed/NCBI
  16. Jozefiak D, Sip A. Bacteriocins in poultry nutrition-A review. Ann Anim Sci 2013;13:449-462 View Article
  17. Mercado V, Olmos J. Bacteriocin production by Bacillus species: Isolation, characterization, and application. Probiotics Antimicrob Proteins 2022;14(6):1151-1169 View Article PubMed/NCBI
  18. Bali V, Panesar PS, Bera MB, Kennedy JF. Bacteriocins: Recent trends and potential applications. Crit Rev Food Sci Nutr 2016;56(5):817-834 View Article PubMed/NCBI
  19. Daba GM, Mostafa FA, Saleh SAA, Elkhateeb WA, Awad G, Nomiyama T, et al. Purification, amino acid sequence, and characterization of bacteriocin GA15, a novel class IIa bacteriocin secreted by Lactiplantibacillus plantarum GCNRC_GA15. Int J Biol Macromol 2022;213:651-662 View Article PubMed/NCBI
  20. Wayah SB, Philip K. Purification, characterization, mode of action, and enhanced production of salivaricin mmaye1, a novel bacteriocin from Lactobacillus salivarius SPW1 of human gut origin. Electron J Biotechnol 2018;35:39-47 View Article
  21. Khorshidian N, Khanniri E, Mohammadi M, Mortazavian AM, Yousefi M. Antibacterial activity of pediocin and pediocin-producing bacteria against Listeria monocytogenes in meat products. Front Microbiol 2021;12:709959 View Article PubMed/NCBI
  22. Verma SK, Sood SK, Saini RK, Saini N. Pediocin PA-1 containing fermented cheese whey reduces total viable count of raw buffalo (Bubalis bubalus) milk. LWT 2017;83:193-200 View Article
  23. Gupta A, Tiwari SK. Probiotic potential of Lactobacillus plantarum LD1 isolated from batter of Dosa, a south Indian fermented food. Probiotics Antimicrob Proteins 2014;6(2):73-81 View Article PubMed/NCBI
  24. Gupta A, Tiwari SK. Plantaricin LD1: A bacteriocin produced by food isolate of Lactobacillus plantarum LD1. Appl Biochem Biotechnol 2014;172(7):3354-3362 View Article PubMed/NCBI
  25. Yadav MK, Tiwari SK. Polydiacetylene vesicles acting as colorimetric sensor for the detection of plantaricin LD1. Anal Biochem 2021;631:114368 View Article PubMed/NCBI
  26. Sheoran P, Tiwari SK. Anti-staphylococcal activity of bacteriocins of food isolates Enterococcus hirae LD3 and Lactobacillus plantarum LD4 in pasteurized milk. 3 Biotech 2019;9(1):8 View Article PubMed/NCBI
  27. Yadav MK, Yadav P, Dhiman M, Tewari S, Tiwari SK. Plantaricin LD1 purified from Lactobacillus plantarum LD1 inhibits biofilm formation of Enterococcus faecalis ATCC 29212 in tooth model. Lett Appl Microbiol 2022;75(3):623-631 View Article PubMed/NCBI
  28. Alves FCB, Barbosa LN, Andrade BFMT, Albano M, Furtado FB, Marques Pereira AF, et al. Short communication: Inhibitory activities of the lantibiotic nisin combined with phenolic compounds against Staphylococcus aureus and Listeria monocytogenes in cow milk. J Dairy Sci 2016;99(3):1831-1836 View Article PubMed/NCBI
  29. Nielsen DS, Cho GS, Hanak A, Huch M, Franz CM, Arneborg N. The effect of bacteriocin-producing Lactobacillus plantarum strains on the intracellular pH of sessile and planktonic Listeria monocytogenes single cells. Int J Food Microbiol 2010;141(Suppl 1):S53-S59 View Article PubMed/NCBI
  30. Chatterjee A, Abraham J. Microbial Contamination and Food Degradation. Academic Press; 2018, 21-47 View Article
  31. Kashani HH, Nikzad H, Mobaseri S. Hoseini ES. Synergism effect of nisin peptide in reducing chemical preservatives in food industry. Life Sci J 2012;9:496-501
  32. Ghosh T, Purkait A, Garai B, Banerjee A. Microbial production of bacteriocins and its applications in food preservation: A review. J Food Technol Pres 2021;5:1-9
  33. Mills S, Serrano LM, Griffin C, O’Connor PM, Schaad G, Bruining C, et al. Inhibitory activity of Lactobacillus plantarum LMG P-26358 against Listeria innocua when used as an adjunct starter in the manufacture of cheese. Microb Cell Fact 2011;10(Suppl 1):S7 View Article PubMed/NCBI
  34. Hanny ELL, Mustopa AZ, Budiarti S, Darusman HS, Ningrum RA, Fatimah. Efficacy, toxicity study, and antioxidant properties of plantaricin E and F recombinants against enteropathogenic Escherichia coli K1.1 (EPEC K1.1). Mol Biol Rep 2019;46(6):6501-6512 View Article PubMed/NCBI
  35. Yi L, Dang Y, Wu J, Zhang L, Liu X, Liu B, et al. Purification and characterization of a novel bacteriocin produced by Lactobacillus crustorum MN047 isolated from koumiss from Xinjiang, China. J Dairy Sci 2016;99(9):7002-7015 View Article PubMed/NCBI
  36. Meng F, Zhao H, Zhang C, Lu F, Bie X, Lu Z. Expression of a novel bacteriocin-the plantaricin Pln1-in Escherichia coli and its functional analysis. Protein Expr Purif 2016;119:85-93 View Article PubMed/NCBI
  37. Wei Y, Wang J, Liu Z, Pei J, Brennan C, Abd El-Aty AM. Isolation and characterization of bacteriocin-producing Lacticaseibacillus rhamnosus XN2 from Yak yoghurt and its bacteriocin. Molecules 2022;27(7):2066 View Article PubMed/NCBI
  38. Gong HS, Meng XC, Wang H. Mode of action of plantaricin MG, a bacteriocin active against Salmonella typhimurium. J Basic Microbiol 2010;50(Suppl 1):S37-S45 View Article PubMed/NCBI
  39. Pei J, Jin W, Abd El-Aty AM, Baranenko DA, Gou X, Zhang H, et al. Isolation, purification, and structural identification of a new bacteriocin made by Lactobacillus plantarum found in conventional kombucha. Food Control 2020;110:106923 View Article
  40. Zhao D, Wang Q, Lu F, Bie X, Zhao H, Lu Z, et al. A novel plantaricin 827 effectively inhibits Staphylococcus aureus and extends shelf life of skim milk. LWT 2022;154:112849 View Article
  41. Barbosa MS, Todorov SD, Ivanova IV, Belguesmia Y, Choiset Y, Rabesona H, et al. Characterization of a two-peptide plantaricin produced by Lactobacillus plantarum MBSa4 isolated from Brazilian salami. Food Control 2016;60:103-112 View Article
  42. Algburi A, Zhang Y, Weeks R, Comito N, Zehm S, Pinto J, et al. Gemini cationic amphiphiles control biofilm formation by bacterial vaginosis pathogens. Antimicrob Agents Chemother 2017;61(12):e00650-17 View Article PubMed/NCBI
  43. Cebrián R, Rodríguez-Cabezas ME, Martín-Escolano R, Rubiño S, Garrido-Barros M, Montalbán-López M, et al. Preclinical studies of toxicity and safety of the AS-48 bacteriocin. J Adv Res 2019;20:129-139 View Article PubMed/NCBI
  44. Bonhi KL, Imran S. Role of bacteriocin in tackling the global problem of multi-drug resistance: An updated review. Biosci Biotechnol Res Commun 2019;12:601-8 View Article
  45. Mukherjee A, Banerjee G, Mukherjee P, Ray AK, Chandra G, Ghosh K. Antibacterial substances produced by pathogen inhibitory gut bacteria in Labeo rohita: Physico-chemical characterization, purification and identification through MALDI-TOF mass spectrometry. Microb Pathog 2019;130:146-155 View Article PubMed/NCBI
  46. Pei J, Huang Y, Ren T, Guo Y, Dang J, Tao Y, et al. The antibacterial activity mode of action of plantaricin YKX against Staphylococcus aureus. Molecules 2022;27(13):4280 View Article PubMed/NCBI
  47. Du H, Zhou L, Lu Z, Bie X, Zhao H, Niu YD, et al. Transcriptomic and proteomic profiling response of methicillin-resistant Staphylococcus aureus (MRSA) to a novel bacteriocin, plantaricin GZ1-27 and its inhibition of biofilm formation. Appl Microbiol Biotechnol 2020;104(18):7957-7970 View Article PubMed/NCBI
  48. Fotso Techeu UD, Kaktcham PM, Momo HK, Foko Kouam EM, Tchamani Piame L, Ngouenam RJ, et al. Isolation, characterization, and effect on biofilm formation of bacteriocin produced by Lactococcus lactis F01 isolated from Cyprinus carpio and application for biopreservation of fish sausage. Biomed Res Int 2022;2022:8437926 View Article PubMed/NCBI
  49. Babic M, Glisic M, Zdravkovc N, Djordjevic J, Velebit B, Ledina T, et al. Inhibition of Staphylococcus aureus by cinnamaldehyde and its effect on sensory properties of milk. IOP Conf Ser: Earth Environ Sci 2019;333:012042 View Article
  50. Ananou S, Muñoz A, Martínez-Bueno M, González-Tello P, Gálvez A, Maqueda M, et al. Evaluation of an enterocin AS-48 enriched bioactive powder obtained by spray drying. Food Microbiol 2010;27(1):58-63 View Article PubMed/NCBI
Copyright © 2024 Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • Journal of Exploratory Research in Pharmacology
  • pISSN 2993-5121
  • eISSN 2572-5505

Article Options

Metrics

Cite this Article

  • © 2024 Xia & He Publishing Inc.
  • Total visits : 2745826
  • Visits today : 2026
Back to Top

Plantaricin LD1 Inhibits the Growth and Biofilm Formation of Staphylococcus aureus in Milk

Manoj Kumar Yadav, Anshu Baldia, Santosh Kumar Tiwari
  • Reset Zoom
  • Download TIFF